These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12951120)

  • 1. Alpha-keto amides as inhibitors of histone deacetylase.
    Wada CK; Frey RR; Ji Z; Curtin ML; Garland RB; Holms JH; Li J; Pease LJ; Guo J; Glaser KB; Marcotte PA; Richardson PL; Murphy SS; Bouska JJ; Tapang P; Magoc TJ; Albert DH; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3331-5. PubMed ID: 12951120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors.
    Vaisburg A; Bernstein N; Frechette S; Allan M; Abou-Khalil E; Leit S; Moradei O; Bouchain G; Wang J; Woo SH; Fournel M; Yan PT; Trachy-Bourget MC; Kalita A; Beaulieu C; Li Z; MacLeod AR; Besterman JM; Delorme D
    Bioorg Med Chem Lett; 2004 Jan; 14(1):283-7. PubMed ID: 14684344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.
    Attenni B; Ontoria JM; Cruz JC; Rowley M; Schultz-Fademrecht C; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3081-4. PubMed ID: 19410459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.
    Dai Y; Guo Y; Guo J; Pease LJ; Li J; Marcotte PA; Glaser KB; Tapang P; Albert DH; Richardson PL; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1897-901. PubMed ID: 12749893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
    Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
    Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protein acetylation induced by novel histone deacetylase inhibitors.
    Glaser KB; Li J; Pease LJ; Staver MJ; Marcotte PA; Guo J; Frey RR; Garland RB; Heyman HR; Wada CK; Vasudevan A; Michaelides MR; Davidsen SK; Curtin ML
    Biochem Biophys Res Commun; 2004 Dec; 325(3):683-90. PubMed ID: 15541343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.
    Andrianov V; Gailite V; Lola D; Loza E; Semenikhina V; Kalvinsh I; Finn P; Petersen KD; Ritchie JW; Khan N; Tumber A; Collins LS; Vadlamudi SM; Björkling F; Sehested M
    Eur J Med Chem; 2009 Mar; 44(3):1067-85. PubMed ID: 18672316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structural characterization and biological evaluation of N-protected cyclopropylethylcarbamates as potential histone deacetylase inhibitor.
    Jung JC; Moon HI; Oh S
    Chem Biol Drug Des; 2008 Dec; 72(6):592-5. PubMed ID: 19090926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis.
    Yang F; Zhang T; Wu H; Yang Y; Liu N; Chen A; Li Q; Li J; Qin L; Jiang B; Wang X; Pang X; Yi Z; Liu M; Chen Y
    J Med Chem; 2014 Nov; 57(22):9357-69. PubMed ID: 25360834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of novel, potent, and selective histone deacetylase inhibitors.
    Jones P; Altamura S; Chakravarty PK; Cecchetti O; De Francesco R; Gallinari P; Ingenito R; Meinke PT; Petrocchi A; Rowley M; Scarpelli R; Serafini S; Steinkühler C
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5948-52. PubMed ID: 16987657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.
    Jones P; Altamura S; De Francesco R; Paz OG; Kinzel O; Mesiti G; Monteagudo E; Pescatore G; Rowley M; Verdirame M; Steinkühler C
    J Med Chem; 2008 Apr; 51(8):2350-3. PubMed ID: 18370373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors.
    Anandan SK; Ward JS; Brokx RD; Bray MR; Patel DV; Xiao XX
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1969-72. PubMed ID: 15808449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice.
    Joung KE; Min KN; An JY; Kim DK; Kong G; Sheen YY
    Cancer Res; 2006 May; 66(10):5394-402. PubMed ID: 16707467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time gene expression analysis in human xenografts for evaluation of histone deacetylase inhibitors.
    Beliën A; De Schepper S; Floren W; Janssens B; Mariën A; King P; Van Dun J; Andries L; Voeten J; Bijnens L; Janicot M; Arts J
    Mol Cancer Ther; 2006 Sep; 5(9):2317-23. PubMed ID: 16985066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors.
    Vaisburg A; Paquin I; Bernstein N; Frechette S; Gaudette F; Leit S; Moradei O; Raeppel S; Zhou N; Bouchain G; Woo SH; Jin Z; Gillespie J; Wang J; Fournel M; Yan PT; Trachy-Bourget MC; Robert MF; Lu A; Yuk J; Rahil J; Macleod AR; Besterman JM; Li Z; Delorme D
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6729-33. PubMed ID: 17977726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.
    Angibaud P; Van Emelen K; Decrane L; van Brandt S; Ten Holte P; Pilatte I; Roux B; Poncelet V; Speybrouck D; Queguiner L; Gaurrand S; Mariën A; Floren W; Janssen L; Verdonck M; van Dun J; van Gompel J; Gilissen R; Mackie C; Du Jardin M; Peeters J; Noppe M; Van Hijfte L; Freyne E; Page M; Janicot M; Arts J
    Bioorg Med Chem Lett; 2010 Jan; 20(1):294-8. PubMed ID: 19906529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor.
    Kim DH; Lee J; Kim KN; Kim HJ; Jeung HC; Chung HC; Kwon HJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):233-8. PubMed ID: 17353008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.